Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Novaliq Gmbh

Clinical trials sponsored by Novaliq Gmbh, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New eye drops aim to tame uveitis without steroids Results expected Oct 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Completed 1

New eye drops aim to tame uveitis without steroids

Disease control Recruiting now

This study tests NOV05, a water-free tacrolimus eye drop, in 20 adults with active non-infectious anterior uveitis. Participants receive either a high or low dose for 6 weeks. The goal is to see if it safely controls inflammation and reduces the need for steroid eye drops.

Phase 2 • Sponsor: Novaliq GmbH • Aim: Disease control

Last updated Jul 30, 2026 00:00 UTC